CS Paper Radar

LLM Agents Perform Controlled Experiments Using Simulation Models

Yuchen Xia, Michael Weyrich, Nasser Jazdi, Johannes Stümpfle, Johannes Sigel, Akshay Narla, Gavin K. Reynolds, Anna Jawor-Baczynska, Pol Llopart

cs.AI cs.CLcs.MAcs.SE ·submitted 2026-08-22 18:54 UTC · v1
published

Abstract

Large language models (LLMs) have shown strong capabilities in reasoning, planning, and tool use, but many scientific and engineering tasks require more than plausible text and code generation. They require understanding how a system responds to intervention, which in practice depends on controlled experimentation. In this work, we propose a multi-agent framework that enables LLM agents to conduct controlled experiments with scientific simulation models for pharmaceutical process design. Given a user query and a baseline configuration, the system constructs a structured task representation, designs experiments, executes comparative simulation, interprets the resulting outcomes, and synthesizes evidence-based recommendations for process parameter optimization. By coupling language models with high-fidelity simulation models in an interactive agent framework, the proposed system supports reasoning through intervention, comparison, and observation. As a result, it produces more specific and actionable outputs than language-only reasoning. In an industrial application setting, this advantage is reflected in higher output specificity as well as improved user-rated correctness and helpfulness. Ablation studies and visualized case analyses further demonstrate the effectiveness and practical utility of simulation-integrated experimental reasoning.

Comment
Accepted at the 31st IEEE International Conference on Emerging Technologies and Factory Automation ETFA 2026

Closest papers

Nearest neighbours by meaning across the whole index.

ClinAgent: A ReAct-Based Agent for Conversational Access to Clinical Trial Information

cs.AI cs.CLcs.IR ·2026-09-12 ·Antonino Vaccarella, Riccardo Cantini, Domenico Talia, Paolo Trunfio, Marianna Talia +2 more
published similarity 0.70
Abstract · Accepted at the CIBB 2026 conference (https://cibb2026.teralab.ai/)

Querying clinical trial registries remains a manual and error-prone process, requiring researchers to navigate large volumes of semi-structured data without support for natural language interaction or cross-source synthesis. To address this, we introduce ClinAgent, a conversational system based on agentic Retrieval-Augmented Generation (RAG) that enables clinicians and researchers to query clinical trial information in plain language and receive grounded, up-to-date responses across multi-turn interactions. The system centers on a Large Language Model (LLM) agent following the ReAct paradigm, which iteratively reasons over queries, selects among a set of integrated tools, and refines its actions based on intermediate outputs. These tools include a ClinicalTrials.gov search interface, a PubMed module, and a Python-based analyzer operating on a locally cached structured dataset of clinical trials. We evaluate the system using a three-phase framework assessing operational effectiveness, planning quality, tool-use efficiency, and expert qualitative judgments, comparing three LLM backends: Gemini 3.0 Flash and two variants of DeepSeek V3.2 (thinking and non-thinking). Results reveal complementary strengths, with DeepSeek (thinking mode) excelling in planning quality, while Gemini achieves the highest overall performance and strongest expert ratings. Overall, our findings highlight the potential of agentic AI systems to improve the accessibility and synthesis of clinical trial information, supporting more efficient and user-centered biomedical research workflows.

0.29

DrugCoding: A Scientific Programming Agent for Drug Discovery

cs.AI cs.MA ·2026-11-10 ·Junwei Hu, Zhuohao Lin, Kun Li, Hengnan Zhang
benchmark similarity 0.69
Abstract

Drug discovery involves multiple interconnected research stages, including molecular design, property prediction, and virtual screening. These processes are characterized by complex workflows, interdependent computational tasks, and diverse specialized tools, placing substantial demands on the coordination of scientific models and computational resources. However, existing large language model (LLM)-based scientific agents still face challenges in autonomous planning of complex tasks, adaptive selection of specialized models, and reliable execution of multi-stage scientific computations, limiting their effectiveness in automating complex drug discovery workflows. To address these challenges, we propose DrugCoding, a scientific programming agent system that integrates scientific task planning, adaptive model routing, multi-agent collaboration, and programmatic tool execution. DrugCoding enables autonomous task planning and dynamic model adaptation for complex research objectives. It can flexibly invoke specialized scientific models, autonomously generate and execute code according to task requirements, and leverage multi-agent collaboration to support efficient execution and reliable validation of complex scientific tasks. To evaluate DrugCoding's performance in scientific tool invocation and multi-stage task execution, we conduct multi-turn tool-calling experiments across diverse language models and scientific tool interfaces. Experimental results demonstrate that DrugCoding achieves an average session-level Pass@1 of 97.35% on the full benchmark, outperforming the strongest baseline, Codex, by 9.24%. On the challenging subset, DrugCoding achieves 97.92%, exceeding the strongest baseline.

0.14

M3OS: A Monte Carlo Graph Search-Orchestrated Multi-Agent LLM System for Evidence-Traced Molecular Optimization

cs.LG q-bio.BM ·2026-09-28 ·Junjie Wang, Yaowei Jin, Ruohui Tang, Guonan Cui, Haojie Wang +5 more
similarity 0.68
Abstract

Small-molecule optimization integrates medicinal-chemistry reasoning and computational evidence through iterative, multi-objective decisions. When large language models (LLMs) reason over optimization histories stored primarily in conversational context, they must recover candidate identities, prior evaluations, and task constraints to guide subsequent decisions. We present M3OS, a multi-agent LLM system that decouples molecular-design reasoning from optimization-state management through Monte Carlo graph search. A persistent graph links evaluated candidates, parent-child transformations and evaluation evidence, while rewards and visit statistics guide LLM-assisted parent selection. Two branches combine tool-driven candidate generation with knowledge- and case-guided medicinal-chemistry editing. An execution harness controls graph updates through structured output extraction, molecular validation and task-bound evaluation. Agents receive role-specific contexts, while the graph preserves optimization trajectories beyond their active contexts. Across three molecular optimization benchmarks, M3OS achieves higher success rates than baselines, supporting the integration of persistent search state, specialized agents and controlled execution for multi-constraint optimization.

0.21

Amortizing Sequential Experimental Design in Reasoning LLMs

cs.LG cs.AI ·2026-10-14 ·Anita Kriz, Antonin Berthon, Nicolás Astorga, Mihaela van der Schaar
benchmark similarity 0.67
Abstract

Despite their extensive pretraining knowledge and strong reasoning capabilities, large language models (LLMs) struggle to adaptively gather information in experimental design tasks. We study how to amortize sequential Bayesian experimental design (BED) into an LLM by explicitly training the reasoning that guides action selection using information-gain rewards. Our approach specifies the experimental generative model independently of the LLM's own beliefs, allowing us to optimize expected information gain under a model of our choosing. We investigate the design choices for amortization, including alternative generative-model constructions, reward estimation, hypothesis-space specification, multi-step objectives, and computational costs relative to training- and inference-time BED baselines. On Twenty Questions, the resulting policies improve information acquisition and task performance, outperform inference- and training-time BED baselines at substantially lower computational cost, and generalize to unseen categories. We further demonstrate positive transfer from Twenty Questions training to Medi-Q, a real-world clinical dialogue benchmark. These results suggest that information gathering can be learned as a generalizable reasoning skill in LLMs.

0.55

Masked Diffusion Language Agents for Tool-Integrated Chemical Reasoning

cs.AI cs.LG ·2026-10-09 ·Mengdi Liu, Chenghao Jia, Hong Chang, Shiguang Shan
top venuebenchmarkcode/data similarity 0.66
Abstract · Accepted at NeurIPS 2026

Designing tool-integrated reasoning agent systems for complex chemical tasks remains a fundamental challenge. Although recent chemical agents have demonstrated promising performance through the integration of external tools, they are still built on the autoregressive paradigm, which is inherently constrained by causal attention and left-to-right generation. As a result, they often struggle with bidirectional molecular understanding, global coordinated tool planning and multi-source evidence integration. To address this challenge, we introduce ChemDiffAgent, the first masked diffusion language agent for tool-integrated chemical reasoning. It reformulates chemical reasoning as iterative denoising over interleaved reasoning and tool-use trajectories, enabling tool-use decisions to be jointly determined under full-trajectory context and thereby better aligning the agent's decision boundary with its knowledge boundary. We further analyze how this paradigm benefits agentic reasoning through harder infilling subproblems during training and flexible arbitrary-order decoding during inference. Then we develop a two-stage post-training framework, comprising agentic supervised fine-tuning and variance-reduced preference optimization, to enhance tool-use and reasoning capabilities. We also construct a comprehensive benchmark covering six chemistry tasks across both single-turn and multi-turn tool-use scenarios. Under matched budgets and evaluation, ChemDiffAgent consistently outperforms autoregressive agents, achieving an overall improvement of approximately 20%. Notably, our 8B model achieves performance comparable to, in some cases surpassing, significantly larger frontier models, such as GPT 5.5 and Claude Opus 4.7. Code is available at https://github.com/bilemond/ChemDiffAgent.

0.42

MADDIE: Multi-Agent Drug Discovery Engine

cs.AI ·2026-10-12 ·Ye Liu, Reza Averly, Avery Meyer, Frazier N. Baker, Ruoxi Gao +2 more
code/data similarity 0.66
Abstract

Drug discovery remains a resource-intensive and time-consuming process, involving billions of dollars and a decade of development to advance a drug to market. While many in silico tools have accelerated this process, operating them still demands substantial time, effort, and expertise from medicinal chemists. Autonomous systems built on Large Language Models (LLMs) have emerged as a promising solution, yet current designs limit their performance. Existing single-agent systems scale poorly to long-horizon, multi-step, and realistic tasks, whereas multi-agent systems typically execute predefined workflows that cannot capture the iterative, non-linear nature of a real drug discovery campaign. Here, we present MADDIE, a multi-agent drug discovery engine. It comprises a central agent, Orchestrator, and four specialized worker agents: HitIdentifier, LeadOptimizer, Synthesizer, and Evaluator, each representing a critical step in a drug discovery campaign. Under Orchestrator's orchestration and coordination, these worker agents are composed into flexible workflows, enabling MADDIE to adapt its strategy and navigate the drug discovery pipeline end-to-end. Across 50 protein targets, MADDIE produces molecules satisfying key property requirements and their synthesis routes, outperforming existing agentic systems, generative models, and general-purpose LLMs by a wide margin. Our analysis reveals how these agents collaborate and that MADDIE can employ different strategies across targets to achieve the campaign's goal, while still being efficient in time and tokens. Together, they demonstrate MADDIE as a low-cost, effective, and efficient autonomous engine for accelerating drug discovery. Code and dataset is available via https://github.com/ninglab/MADDIE.

0.49

From Atomic to Agentic: Towards Interpretable Evaluation of LLMs' Agentic Mathematical Capabilities

cs.AI cs.CL ·2026-08-27 ·Jiayi Kuang, Yinghui Li, Yunze Song, Keyu Chen, Zhifeng Shen +9 more
top venuebenchmark similarity 0.66
Abstract · EMNLP 2026

Large Language Models (LLMs) are evolving from performing end-to-end mathematical reasoning to integrating agentic intelligence. However, most existing math benchmarks evaluate only final answers. This outcome-oriented evaluation provides limited diagnostic value for identifying process-level failures or rigorous logic, failing to guide the transformation of LLMs into robust agents. To bridge this gap, we present a process-level benchmark designed to evaluate the inherent agentic mathematical reasoning abilities of LLMs. Our framework aligns problem-solving agentic behaviors with a structured taxonomy of reusable mathematical atomic capabilities. We design a comprehensive suite of planning, action, and feedback tasks across both textual and multimodal contexts, supported by an automated pipeline that synthesizes high-quality trajectories and produces fine-grained annotations via controlled LLM rewriting. Experiments reveal that models with similar end-to-end accuracy can exhibit markedly different agentic capability profiles. This demonstrates that process-level evaluation is crucial for interpreting the true potential of LLMs and guiding the development of next-generation mathematical agents.

0.58

little m: An AI Agent for Industrial Process Optimization

cs.AI ·2026-09-15 ·Yongchao Ye, Xinyu He, Dutliff Boshoff, Way Kuo, Lishuai Li
top venuebenchmarkcode/data similarity 0.65
Abstract

Manufacturing consumes one third of global energy and still has significant room for improvement in terms of energy efficiency. Optimal process control is essential for this purpose. However, synthesizing mathematical optimization models from messy, real-world industrial specifications requires bridging unstructured natural language and spatial diagrams with rigorous mathematical syntax. This poses a profound challenge for general-purpose Large Language Models (LLMs), which may introduce invalid constraints when tasked with modeling continuous multi-physics dynamics. To address this, we introduce little m, an AI agent designed to assist the formulation of industrial process control models. Combining a domain-specific knowledge repository with LLM-driven interaction, the proposed framework formulates real-world optimization problems as mathematical models. For systematic evaluation, we introduce the Industrial Process Control Benchmark (IPC-Bench), a novel multimodal dataset of 50 canonical scenarios requiring joint reasoning over text and process diagrams. Through comprehensive automated structural assessments and double-blind human evaluation, little m substantially outperforms state-of-the-art LLMs, generating semantically correct models. These evaluations assess formulation quality rather than solver feasibility, formal physical validity, or closed-loop industrial performance. The implementation of little m and the IPC-Bench dataset are available at https://github.com/yeyongchao/process-modeling-benchmark.

0.47